AbbVie Inc. Current Liabilities 2012-2026 | ABBV
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is AbbVie Inc.'s current current liabilities?
AbbVie Inc. (ABBV) annual current liabilities for 2025 was $43.29B, a 11.72% increase from 2024. AbbVie Inc. current liabilities for the quarter ending March 31, 2026 was $42.10B.
What was AbbVie Inc.'s current liabilities in 2024?
AbbVie Inc. annual current liabilities for 2024 was $38.75B, a 2.40% increase from 2023.
What was AbbVie Inc.'s current liabilities in 2023?
AbbVie Inc. annual current liabilities for 2023 was $37.84B, a 28.11% increase from 2022.
What is AbbVie Inc.'s 5-year current liabilities CAGR?
AbbVie Inc. current liabilities grew at a compound annual growth rate (CAGR) of 8.60% from FY2020 to FY2025, going from $28.66B to $43.29B over 5 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+8.6%
FY2020
$28.66B
→
FY2025
$43.29B
1213141516171819202122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $43.29B | +11.7% | 10-K |
| FY2024 | $38.75B | +2.4% | 10-K |
| FY2023 | $37.84B | +28.1% | 10-K |
| FY2022 | $29.54B | -16.1% | 10-K |
| FY2021 | $35.19B | +22.8% | 10-K |
| FY2020 | $28.66B | +83.9% | 10-K |
| FY2019 | $15.59B | -9.6% | 10-K |
| FY2018 | $17.24B | +3.6% | 10-K |
| FY2017 | $16.64B | +70.1% | 10-K |
| FY2016 | $9.78B | -10.2% | 10-K |
| FY2015 | $10.89B | -4.4% | 10-K |
| FY2014 | $11.39B | +65.6% | 10-K |
| FY2013 | $6.88B | +1.5% | 10-K |
| FY2012 | $6.78B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →